Ambe Phytoextracts Private Limited

Ambe Phytoextracts Private Limited - fmcg in Delhi, India. FY 2026 financials & compliance.
CIN U51101DL2007PTC165275 Incorporated 27 June 2007 ROC Delhi HQ Delhi, India
Active Private Limited Company FMCG MSME · Small
Revenue · FY 2025
₹52.25 Cr
▲ 6% YoY
Net profit · FY 2025
₹3.5 Cr
Net margin 6.7%
EBITDA · FY 2025
₹7.5 Cr
EBITDA margin 14.4%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹50 Lakh
Issued & subscribed
Open charges
₹13.2 Cr
Satisfied ₹16.58 Cr
Company age
19 yrs
Est. 2007
Employees · EPFO
132
Provident fund records

About Ambe Phytoextracts Private Limited

Data last updated:

Ambe Phytoextracts Private Limited is a private limited company based in Delhi, India. It operates in the personal care and skincare products segment of the FMCG sector. It was incorporated on 27 June 2007 and has been in existence for over 19 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51101DL2007PTC165275. Its GSTIN is 07AAGCA4375B1ZY (Delhi). The company holds 3 GST registrations, all of them active.

The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors including Harsh Pal Singh (Managing Director) and Beena Singh (Whole-Time Director).

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D – 202 Ifuna Cghsl Plot No.55 Balco Market Ip Extension Patparganj, Delhi, India – 110092.

As per the financials filed for FY 2025, the company reported a revenue of ₹52.25 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹3.5 Cr (net margin 6.7%) and EBITDA of ₹7.5 Cr (EBITDA margin 14.4%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 4% over five years.

The company has about 132 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Ambe Phytoextracts. As per MCA filings, the company has open charges of ₹13.2 Cr and satisfied charges of ₹16.58 Cr on record. Court records list 4 cases involving the company, including 3 filed by the company and 1 filed against it. The company has 1 deal on record (1 funding round), with disclosed funding of ₹40 Lakh; the latest was in March 2010. Its 8 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is Halcyon Labs Private Limited with revenue of ₹52.86 Cr. The company has 14 MSME Form 1 returns on record between 2019 and 2024, listing 258 overdue payments to 36 micro and small suppliers.

Ambe Phytoextracts Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-02-0007262). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ambe-group.com.

Company details

CIN U51101DL2007PTC165275
Registration Number 165275
Incorporation Date 27 June 2007
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-02-0007262

Recognitions & Rankings of Ambe Phytoextracts

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-DL-02-0007262

Contact details

Ambe Phytoextracts Private Limited's registered office is in Delhi, Delhi. Its website is ambe-group.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    D – 202 Ifuna Cghsl Plot No.55 Balco Market Ip Extension Patparganj, Delhi, India – 110092
  • Industry
    FMCG, Personal Care & Skincare Products

To see the full contact details of Ambe Phytoextracts Private Limited, buy the company report.

Comprehensive company report
Ambe Phytoextracts Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Ambe Phytoextracts operates one associated brand: Ambe Phytoextracts. Each brand links to its own profile.

BrandDescriptionWebsite
Manufacturing of natural ingredients and extracts for healthcare, FMCG, and personal care.ambe-group.com

Business activity

The main business activities of Ambe Phytoextracts are manufacturing and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and wholesale trading. 2 activity segments are registered with the MCA.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Ambe Phytoextracts Private Limited, buy the company report.

Financials of Ambe Phytoextracts Private Limited

FY 2025 filings available

Ambe Phytoextracts Private Limited reported revenue of ₹52.25 Cr (up 6% YoY) for FY 2025.

Revenue · FY 2025
₹52.25 Cr ▲ 6%
Net profit · FY 2025
₹3.5 Cr margin 6.7%
EBITDA · FY 2025
₹7.5 Cr margin 14.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 6%
3 years · compounded
▲ 5%
5 years · compounded
▲ 4%
EBITDA CAGR growth
1 year
▲ 11%
3 years · compounded
▲ 17%
5 years · compounded
▲ 16%

Revenue has grown at a compounded annual rate (CAGR) of 4% over five years, including 6% growth in the latest year. EBITDA rose 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹7.5 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹3.5 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin14.4%
Net Profit Margin6.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Ambe Phytoextracts Private Limited, buy the company report.

Board of directors of Ambe Phytoextracts Private Limited

Ambe Phytoextracts has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Harsh Pal SinghManaging Director27 Jun 200719 Years 4 MonthsCurrent
Renu RawatDirector22 Jan 20197 Years 9 MonthsCurrent
Beena SinghWhole-Time Director27 Jun 200719 Years 4 MonthsCurrent

Peer comparison

Ambe Phytoextracts Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Halcyon Labs Private Limited₹52.86 Cr (FY 2024)-4.0%Mumbai, Maharashtra, India
Flax Laboratories Private Limited₹52.86 Cr (FY 2025)26.0%Mahad, Maharashtra, India
Vani Pharma Labs Limited₹52.6 Cr (FY 2020)40.0%Hyderabad, Telangana, India
Om Biomedic Private Limited₹52.57 Cr (FY 2024)-6.0%Hisar, Haryana, India
Ambe Phytoextracts Private Limitedthis company₹52.25 Cr (FY 2025)₹3.5 Cr6.7%6.0%132Delhi, India
Unilab Chemicals and Pharmaceuticals Private Limited₹51.94 Cr (FY 2024)5.0%Mumbai, Maharashtra, India
Vincit Labs Private Limited₹51.7 Cr (FY 2025)-12.0%New Delhi, Delhi, India
K. A. Malle Pharmaceuticals Limited₹51.47 Cr (FY 2025)3.0%Mumbai, Maharashtra, India
Ranq Remedies Private Limited₹51.43 Cr (FY 2025)5.0%Thane, Maharashtra, India

To see the full peer comparison of Ambe Phytoextracts Private Limited, buy the company report.

Auditor

Ambe Phytoextracts Private Limited is audited by NARENDER SINGH & CO. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
NARENDER SINGH & CO.FY 2023030207N

Shareholding

The shareholding of Ambe Phytoextracts Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Ambe Phytoextracts Private Limited, buy the company report.

Charges & borrowings

Open charges
₹13.2 Cr
Satisfied charges
₹16.58 Cr
Breakdown by lending institutions
Yes Bank Limited₹12.82 Cr
Others₹0.18 Cr
Hdb Financial Services Limited₹0.11 Cr
Hdfc Bank Limited₹0.10 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
10 Jun 2025101136732Hdb Financial Services Limited₹10.6 LakhOpen
27 Jun 2024100958047Yes Bank Limited₹12.82 CrOpen
15 Sep 2023100813598Others₹9.6 LakhOpen
30 Sep 2022100657081Others₹8.36 LakhOpen
22 Jun 2021100470890Hdfc Bank Limited₹9.89 LakhOpen

To see the full charge records of Ambe Phytoextracts Private Limited, buy the company report.

Total charge records: 15 View all charges

Deals & funding

Ambe Phytoextracts Private Limited has 1 deal on record (1 funding round), with disclosed funding of ₹40 Lakh; the latest was in March 2010.

Total deals
1
Funding round
1
Disclosed funding
₹40 Lakh

Deals on record (1 of 1)

WhenDealAmountParties
Mar 2010Funding round₹40 Lakh

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Ambe Phytoextracts Private Limited has 14 MSME Form 1 returns on record between 2019 and 2024, listing 258 overdue payments to 36 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 36)

SupplierAmount dueDue sinceReported on
an individual supplier
an individual supplier
Amar Polyfils Pvt Ltd
an individual supplier
an individual supplier

To see the full MSME payment records of Ambe Phytoextracts Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Ambe Phytoextracts Private Limited has a workforce of 132 employees on its EPFO records as of May 2026, across 2 active EPFO establishments.

Employee count
132
Active EPFO establishments
2
Employee growth
-6.4%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-27132
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Ambe Phytoextracts Private Limited, buy the company report.

GST

Ambe Phytoextracts has 3 GST registrations: 3 active.

Total GSTINs
3
Active
3
GSTINStateStatusRegistered on
07AAGCA4375B1ZYDelhiActive01 Jul 2017
05AAGCA4375B1Z2UttarakhandActive01 Jul 2017
09AAGCA4375B1ZUUttar PradeshActive28 Nov 2020

To see the full GST registrations and return filing status of Ambe Phytoextracts Private Limited, buy the company report.

Recent activity

Ambe Phytoextracts Private Limited has 6 board changes on record since 2007: 3 appointments and 3 cessations. The latest: Muskan Choudhary ceased to be Director on 31 Jan 2024.

AGM
Ambe Phytoextracts Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Hdb Financial Services Limited amounted to Rs. 10.60 Lakh with Charge ID 101136732 was registered on 10 Jun 2025.
Filing
Ambe Phytoextracts Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge registered on 19 Dec 2020 via Charge ID 100410086 with Axis Bank Limited was fully satisfied on 22 Oct 2024.
Charges
A charge with Yes Bank Limited amounted to Rs. 1,282.00 Lakh with Charge ID 100958047 was registered on 27 Jun 2024.
Charges
A charge registered on 23 Jun 2021 via Charge ID 100474437 with Hdfc Bank Limited was fully satisfied on 12 Jun 2024.
Charges
A charge registered on 23 May 2018 via Charge ID 100183312 with Bank Of India was fully satisfied on 01 Feb 2024.
Ceased
Muskan Choudhary ceased to be Director.
Charges
A charge with Others amounted to Rs. 9.60 Lakh with Charge ID 100813598 was registered on 15 Sep 2023.
Charges
A charge registered on 13 Jun 2018 via Charge ID 100193748 with Hdfc Bank Limited was fully satisfied on 26 Jun 2023.
Charges
A charge registered on 09 Aug 2019 via Charge ID 100291570 with Bank Of India was fully satisfied on 19 Jun 2023.
Charges
A charge registered on 17 Dec 2021 via Charge ID 100517011 with Axis Bank Limited was fully satisfied on 18 Mar 2023.

24 earlier events are in the company report.

Frequently asked questions

Ambe Phytoextracts is an active private limited company based in Delhi, India. The company works in personal care and skincare products, within the FMCG industry. It was incorporated on 27 June 2007 (19+ years old) and is registered under CIN U51101DL2007PTC165275.

Ambe Phytoextracts has 3 current directors:

The latest financial statements of Ambe Phytoextracts on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Ambe Phytoextracts is 07AAGCA4375B1ZY, registered in Delhi. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 05AAGCA4375B1Z2 (Uttarakhand), 09AAGCA4375B1ZU (Uttar Pradesh).

The CIN (Corporate Identification Number) of Ambe Phytoextracts is U51101DL2007PTC165275. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Ambe Phytoextracts has 4 court cases on record: 3 filed by the company and 1 filed against it. Most are in the district courts.

Ambe Phytoextracts was incorporated on 27 June 2007, making it 19+ years old. It is registered with the Registrar of Companies, Delhi.

Ambe Phytoextracts has 1 deal on record (1 funding round), with disclosed funding of ₹40 Lakh; the latest was in March 2010.

The peers of Ambe Phytoextracts by revenue are Halcyon Labs Private Limited, Flax Laboratories Private Limited, Vani Pharma Labs Limited, Om Biomedic Private Limited, Unilab Chemicals and Pharmaceuticals Private Limited and 3 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Muskan Choudhary ceased to be Director on 31 Jan 2024. Beena Singh ceased to be Director on 01 Apr 2022. Harsh Pal Singh ceased to be Director on 01 Apr 2022. Ambe Phytoextracts has 6 board changes on record in total.

Yes, Ambe Phytoextracts is registered as a small enterprise under Udyam registration (number: UDYAM-DL-02-0007262).

Ambe Phytoextracts has 14 MSME Form 1 returns on record between 2019 and 2024, listing 258 overdue payments to 36 micro and small suppliers. The latest return was filed on 02 May 2024.